|
Volumn 67, Issue 24, 2016, Pages 2905-2906
|
The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
FIBRINOGEN RECEPTOR ANTAGONIST;
BIORESORBABLE SCAFFOLD;
CLINICAL EFFECTIVENESS;
DRUG ELUTING STENT;
FOLLOW UP;
HUMAN;
IMPLANTATION;
LETTER;
OPERATOR;
PERCUTANEOUS CORONARY INTERVENTION;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
REVASCULARIZATION;
RISK ASSESSMENT;
SAFETY;
THROMBOSIS;
ADVERSE DEVICE EFFECT;
BIODEGRADABLE IMPLANT;
DEVICES;
HEALTH CARE SURVEY;
PATIENT CARE;
PROCEDURES;
STATISTICS AND NUMERICAL DATA;
TISSUE REGENERATION;
TISSUE SCAFFOLD;
VASCULAR CLOSURE DEVICE;
ABSORBABLE IMPLANTS;
FOLLOW-UP STUDIES;
GUIDED TISSUE REGENERATION;
HEALTH CARE SURVEYS;
HUMANS;
PATIENT CARE MANAGEMENT;
PERCUTANEOUS CORONARY INTERVENTION;
THROMBOSIS;
TISSUE SCAFFOLDS;
VASCULAR CLOSURE DEVICES;
|
EID: 84979574776
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2016.03.576 Document Type: Letter |
Times cited : (7)
|
References (5)
|